Adirondack Trust CO Astrazeneca PLC Transaction History

Adirondack Trust CO

$297 Million
Q4 2025

A detailed history of Adirondack Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Adirondack Trust CO holds 1,102 shares of AZN stock, worth $98,518. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,102

Previous 1,015 8.57%

Holding current value

$98,518

Previous $77,000 27.27%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 08, 2026	BUY	$81.15 - $89.4 $7,060 - $7,777	87 Added 8.57%	1,102 $98,000
Q3 2025 Oct 20, 2025	BUY	$68.72 - $82.11 $16,286 - $19,460	237 Added 30.46%	1,015 $77,000
Q2 2024 Jul 09, 2024	SELL	$66.81 - $80.83 $15,433 - $18,671	-231 Reduced 22.89%	778 $60,000
Q1 2024 Apr 09, 2024	BUY	$61.03 - $69.57 $610 - $695	10 Added 1.0%	1,009 $68,000
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $40,477 - $43,893	579 Added 137.86%	999 $71,000

Q2 2021 Jul 15, 2021	SELL	$48.42 - $60.18 $2,663 - $3,309	-55 Reduced 11.58%	420 $25,000
Q2 2020 Aug 19, 2020	BUY	$43.1 - $55.31 $2,370 - $3,042	55 Added 13.1%	475 $26,000
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $1,061 - $1,261	25 Added 6.33%	420 $20,000
Q3 2019 Oct 09, 2019	BUY	$40.12 - $45.47 $2,005 - $2,273	50 Added 14.49%	395 $18,000
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $887 - $1,075	25 Added 7.81%	345 $13,000
Q1 2018 May 03, 2018	SELL	$32.97 - $36.63 $2,143 - $2,380	-65 Reduced 16.88%	320 $11,000
Q4 2017 Jan 10, 2018	SELL	$32.09 - $34.78 $2,085 - $2,260	-65 Reduced 14.44%	385 $13,000
Q3 2017 Oct 12, 2017	BUY	$28.96 - $34.0 $13,032 - $15,300	450	450 $15,000

Others Institutions Holding AZN

# of Institutions

1,505

Shares Held

501M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.

Account

Adirondack Trust CO Astrazeneca PLC Transaction History